|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Atlas Arteria Group is an Australia-based global owner, operator and developer of toll roads, with a portfolio of four toll roads in France, Germany and the United States. The Company's portfolio assets include the Autoroutes Paris-Rhin-Rhone (APRR), Autoroute des deux lacs (ADELAC), Dulles Greenway and Warnow Tunnel. The Company owns approximately 31.14% interest in the APRR toll road group in France. In addition to the APRR business is the smaller ADELAC business which connects to APRR in south-east France. Together APRR and ADELAC comprise a 2,318km motorway network located in the East and Southeast of France. In the United States, the Company holds 100% of the economic interest in the Dulles Greenway is located approximately 22 kilometers toll road in the Commonwealth of Virginia. In Germany, the Company owns 100% of the Warnow Tunnel in the north-east city of Rostock.
Upcoming Events for ALX
Half Year 2022 Atlas Arteria Group Earnings Release
Q3 2022 Atlas Arteria Group Traffic and Revenue Data
As of Today at 07:02 UTC, shares in Atlas Arteria are trading at AU$7.03. This share price information is delayed by 15 minutes.
Shares in Atlas Arteria last closed at AU$7.03 and the price had moved by +14.5% over the past 365 days. In terms of relative price strength the Atlas Arteria share price has outperformed the ASX All Ordinaries Index by +14.12% over the past year.
The overall consensus recommendation for Atlas Arteria is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Atlas Arteria dividend yield is 5.12% based on the trailing twelve month period.
Last year, Atlas Arteria paid a total dividend of AU$0.36, and it currently has a trailing dividend yield of 5.12%. We do not have any data on when Atlas Arteria is to next pay dividends.
We do not have data on when Atlas Arteria is to next pay dividends. The historic dividend yield on Atlas Arteria shares is currently 5.12%.
To buy shares in Atlas Arteria you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$7.03, shares in Atlas Arteria had a market capitalisation of AU$6.74bn.
Here are the trading details for Atlas Arteria:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ALX
Based on an overall assessment of its quality, value and momentum Atlas Arteria is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Atlas Arteria is AU$7.12. That is 1.21% above the last closing price of AU$7.03.
Analysts covering Atlas Arteria currently have a consensus Earnings Per Share (EPS) forecast of AU$0.57 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Atlas Arteria. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +8.31%.
As of the last closing price of AU$7.03, shares in Atlas Arteria were trading +6.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Atlas Arteria PE ratio based on its reported earnings over the past 12 months is 12.08. The shares last closed at AU$7.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Atlas Arteria's management team is headed by:
- Jeffrey Conyers - NEC
- Debra Goodin - NEC
- Graeme Bevans - CEO
- Nadine Lennie - CFO
- Vincent Portal-Barrault - COO
- Clayton McCormack - GCN
- Paul Lynch - SEC
- Ariane Barker - NID
- David Bartholomew - NID
- Fiona Beck - NID
- Andrew Cook - NID
- Caroline Foulger - NID
- Jean-Georges Malcor - NID